NASDAQ: LPCN · Life Sciences · 10 alerts · CIK 1535955
Share price
$1.66Close, Nov 16
Market cap
$18.4M
Shares outstanding
11.07MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lipocine Inc. filings on SEC EDGAR ↗
Mahesh V. Patel, CEO, bought 50,000 shares of Lipocine Inc. at $1.58 to $1.60 a share (average $1.59) in 2 transactions, worth $79.5K in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 211,495 (+13.4%).
Lipocine Insider John W. Higuchi Buys $55K of Stock
John W. Higuchi bought 25,007 shares of Lipocine Inc. at $2.15 to $2.23 a share (average $2.20) in 2 transactions, worth $55K in total between Sep 29, 2026 and Sep 30, 2026. Shares held after the trade: 241,365 (+7.1%).
Lipocine Insider John W. Higuchi Buys $27.1K of Stock
John W. Higuchi bought 12,561 shares of Lipocine Inc. at $2.16 a share, worth $27.1K in total on Sep 28, 2026. Shares held after the trade: 216,358 (+6.2%).